Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Lots of depth to Onc data needs to be understood

<< Previous

Bullboard Posts

Next >>

Comment by Conquistador1on Dec 19, 2021 9:17am

199 Views

Post# 34244478

RE:RE:Lots of depth to Onc data needs to be understood

fasttrack5, I don't plan on posting very much. This is just a nostalgia tour for me. I sold all my stock between $8 and $9. I have never been tempted to buy it back. I want to make sure that the blood on the street isn't mine.
The analysts had the same price targets when I sold the stock, don't get seduced by talk.
GLTA

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario